Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension
Sign Up to like & getrecommendations! Published in 2022 at "Respiratory Medicine Case Reports"
DOI: 10.1016/j.rmcr.2022.101592
Abstract: The effective therapy for pulmonary arterial hypertension (PAH) with inadequate clinical response is scarce except for lung transplantation when prostacyclin infusion is ineffective. The purpose of this study is to investigate the efficacy and safety… read more here.
Keywords: infusion; selexipag; infusion analogs; pulmonary arterial ... See more keywords